Spady D K, Turley S D, Dietschy J M
J Clin Invest. 1985 Sep;76(3):1113-22. doi: 10.1172/JCI112066.
Receptor-independent low density lipoprotein (LDL) transport plays a critical role in the regulation of plasma cholesterol levels; hence, these studies were done to characterize this process in the tissues of the rat. High rates of receptor-independent clearance were found in the spleen, but other organs, like liver, gastrointestinal tract, and endocrine glands manifested lower clearance rates that varied from 3 to 9 microliter/h per g, while the rates in nervous tissue, muscle, and adipose tissue were less than 1 microliter/h per g. Receptor-dependent uptake was much higher in liver (85 microliter/h per g) and adrenal gland (219 microliter/h per g), but was also low in most other tissues. At normal plasma LDL concentrations, 67% of the receptor-dependent transport in the whole animal was accounted for by LDL uptake in the liver. In contrast, the receptor-independent uptake found in the whole animal took place in many organs, including skeletal muscle (20%), liver (16%), small bowel (15%), skin (10%), and spleen (7%). Furthermore, in liver, the rate of cholesterol synthesis could be varied 11-fold, yet the rate of receptor-independent LDL clearance remained constant at approximately 8 microliter/h per g. When the circulating levels of LDL were systematically increased, receptor-independent LDL clearance also remained constant, so that hepatic LDL-cholesterol uptake by this mechanism increased linearly, from 1 to 20 micrograms/h per g, as the plasma LDL-cholesterol level was increased from 10 to 250 mg/dl. Finally, when equal amounts of LDL-cholesterol were delivered into the liver by either the receptor-dependent or receptor-independent mechanism, there was significant suppression of cholesterol synthesis and an increase in cholesteryl esters. Thus, in any situation in which receptor-dependent LDL degradation is lost, cholesterol balance in the whole animal and across individual organs is maintained by receptor-independent mechanisms, although when the new steady state is achieved, circulating levels of LDL must necessarily be very much increased.
不依赖受体的低密度脂蛋白(LDL)转运在血浆胆固醇水平的调节中起关键作用;因此,进行了这些研究以表征大鼠组织中的这一过程。在脾脏中发现了高比率的不依赖受体的清除率,但其他器官,如肝脏、胃肠道和内分泌腺,其清除率较低,在每克3至9微升/小时之间变化,而神经组织、肌肉和脂肪组织中的清除率低于每克1微升/小时。依赖受体的摄取在肝脏(每克85微升/小时)和肾上腺(每克219微升/小时)中要高得多,但在大多数其他组织中也较低。在正常血浆LDL浓度下,整个动物中67%的依赖受体的转运是由肝脏摄取LDL所致。相比之下,在整个动物中发现的不依赖受体的摄取发生在许多器官中,包括骨骼肌(20%)、肝脏(16%)、小肠(15%)、皮肤(10%)和脾脏(7%)。此外,在肝脏中,胆固醇合成速率可变化11倍,但不依赖受体的LDL清除率保持恒定,约为每克8微升/小时。当LDL的循环水平系统性升高时,不依赖受体的LDL清除率也保持恒定,因此随着血浆LDL-胆固醇水平从10毫克/分升升高至250毫克/分升,通过这种机制肝脏对LDL-胆固醇的摄取呈线性增加,从每克1微克/小时增加至20微克/小时。最后,当通过依赖受体或不依赖受体的机制将等量的LDL-胆固醇输送到肝脏时,胆固醇合成受到显著抑制,胆固醇酯增加。因此,在任何依赖受体的LDL降解丧失的情况下,尽管达到新的稳态时LDL的循环水平必然会大幅升高,但整个动物和各个器官的胆固醇平衡通过不依赖受体的机制得以维持。